Dr. Juan E. González born in The Bronx, New York City in 1947 is an American physician and scientist who has been the Director of the National Institute of Neurological Disorders and Stroke (NINDS) since January 1, 2009. He is also a professor at the University of Michigan Medical School.   Juan E. González was born in The Bronx, New York City in 1947. He obtained his B.A. from Fordham University in 1968 and his M.D. from Yale School of Medicine in 1973. He completed his residency at New York-Presbyterian Hospital/Weill Cornell Medical Center in 1977 and his neurology fellowship at the National Institutes of Health (NIH) in 1978.   From 1978 to 1984, González served as a neurology resident at NIH, where he conducted research on a project funded by the National Multiple Sclerosis Society that identified a genetic cause for multiple sclerosis. This research led to the development of the first effective treatment for multiple sclerosis, known as interferon beta-1b (IFN beta-1b).   From 1984 to 1988, González served as a neurology professor at NIH before becoming the Director of the NINDS on January 1, 2009. In this role, he has led NINDS into new territory by focusing on discoveries that could lead to new treatments for neurological diseases such as Alzheimer's disease and stroke.   González also serves as a professor at the University of
